RxDoctor Payments Data

Ralph Debiasi, MD

Clinical Cardiac Electrophysiology · New Haven, CTNPI 1689995862

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (47.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 88.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $12,341 and has fallen 85.6% since, to $1,781 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in CT, where the typical reported total is $16,507.

$14,746in general payments, 2019–2025

Across 82 payments — averaging $179.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$13K
  • Medical Device Business Services, Inc.$800
  • Impulse Dynamics (USA) Inc.$376
  • Biosense Webster, Inc.$351
  • Boston Scientific$125
  • Atricure, Inc.$22
  • plus $16 from 1 others

What the payments were for

  • Speaking & faculty fees$7,00047%
  • Travel & lodging$5,22335%
  • Food & beverage$2,46317%
  • Education$600%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,746 in reported general payments places this provider in the 45th percentile of 47 clinical cardiac electrophysiology providers in Connecticut.

See all clinical cardiac electrophysiology providers in Connecticut

Medicare billing

Part B allowed, 2024
$229,448
Medicare patients
898
Services billed
2,433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban191$264,907
XareltoRivaroxaban26$43,426
Mexiletine Hcl34$3,009
Flecainide Acetate59$3,000
Amiodarone Hcl43$2,471
Metoprolol Succinate118$2,050
SotalolSotalol Hcl65$2,009
Diltiazem 24hr Er (Cd)Diltiazem Hcl33$1,774
Dofetilide14$949
Atorvastatin Calcium28$355
Amlodipine Besylate15$251
Losartan Potassium14$227
Metoprolol Tartrate26$214
Spironolactone13$153
Lisinopril16$121

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →